AQST

MKT CAP:$502M

Aquestive Therapeutics Inc

Market Cap

$502M

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NASDAQ

Healthcare·Drug·🇺🇸·NASDAQ

Stock Price

$3.93-$2.52 (-39.07%)

Jun 5, 2026

52W High $7.4952W Low $2.95

Company Details

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formul...

CEO

—

IPO Date

Jul 25, 2018

Website

www.aquestive.com

Key Metrics TTM

Revenue

$50M

-7.3% YoY

Net Income

-$69M

EPS (Diluted)

Free Cash Flow

-$44M

Revenue / Share

$0.41

Gross Margin

63.5%

Operating Margin

-111.2%

Net Margin

-137.1%

FCF Margin

-88.2%

P/S

10.0x

P/E

Earnings Reports

Q2 2026

Aug 11, 2026

PENDING

Q1 2026

May 13, 2026

$14M+65.7%

FY 2025

Mar 4, 2026

$45M-22.6%

Q4 2025

Mar 4, 2026

$13M+9.7%

Q3 2025

Nov 5, 2025

$13M-5.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee